2
ANTIMICROBIAL THERAPY
Antimicrobial Therapy: Being a Good Steward
Healthcare in the 20
th
century was forever changed when antibiotics were discovered
(Barlam et al., 2016). Antibiotics reduced infectious diseases ability to cause morbidity and
mortality and gave way for significant developments in medicine (Barlam et al., 2016). However
misuse and overuse have led to the increase of antibiotic resistant strands of organisms and
antibiotic development is struggling to keep up (Barlam et al., 2016; Arcangelo, Peterson,
Wilbur, & Reinhold, 2017). The need to optimize antibiotic use is clear (Barlam et al., 2016).
The goal of antibiotic stewardship is to systematize interventions to improve and quantify the
correct use of antimicrobial agents by encouraging the selection of the most favorable regimen
(Barlam et al., 2018). The purpose of this paper is to discuss the many categories and differences
of
antimicrobial agents and relay the importance of proper identification of the causative
microorganism in antimicrobial therapy selection.
Antimicrobial Agents
Since the first successful isolation of the penicillin were found to treat streptococcal and
staphylococcal infections, 19 more categories of antimicrobial agents were discovered
(Arcangelo et al., 2017). Each category has a different target of action and some contain many
different agents (Arcangelo et al, 2017) The 20 categories of antimicrobial agents are:
Penicillins, beta-lactam/beta-lactamase inhibitor combinations, four generations of
cephalosporins, monobactams, carbapenems, fluroquinolones (FQ), macrolides,
aminoglycosides, tetracyclines, glycylcyclines, sulfonamides, glycopeptides, oxazolidinones,
lipopeptides, streptogramins, antianaerobic agents, and miscellaneous agents (Arcangelo et al.,
2017).
